100% Cured with Combo
After promising hep C trials, docs are thinking about prescribing the drug blend "off-label."
Protease inhibitor, Simeprevir cured 4 out of 5 people with hepatitis C in Janssen's phase III clinical trials.
AbbVie's five-drug HCV combo therapy demonstrated over 90% cure rates in phase IIb studies.
The Perfect Combination?
BMS is boasting high cure rates with its all-oral interferon and ribavirin-free hep C combination treatment.
2 HIV Drugs Might Control Hepatitis B
Combo therapy suppresses "immune-tolerant" HBV infections in 75% of trial participants.
EASL 2013 Kicks Off
Visit the event's main website for more information.